Metacrine, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate MET642 in Patients With NASH (NCT04773964) | Metacrine, Inc. | 2021-03-03 |
| Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH (NCT04702490) | Metacrine, Inc. | 2020-12-15 |
Track Metacrine, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.